The MHRA has said it is now working closely with the Department of Health and Social Care and other healthcare partners on coronavirus and they are prioritising work including supporting and authorising the development of vaccines, clinical trials of medicines, and managing the supply of medicines and healthcare products.
They will continue to monitor the safety of medicinal products and provide updates through our information channels and alert systems. Below is their monthly medication safety update.
Loading...
Reload document 
Open in new tab
This circular is being shared under the Open Government Copyright licence.
Begin the discussion right here